SavedAdd your journal

Journals / Bilişsel Davranışçı Psikoterapi ve Araştırmalar Dergisi / 2022 / Cilt: 11 - Sayı: 1

Cognitive Behavioral Therapy for Female Patients with Fibromyalgia Syndrome: A Pilot Trial

Fibromiyaljili Kadın Hastalarda Bilişsel Davranışçı Terapi: Bir Pilot Çalışma

Gülşen TEKSİN
Özge ŞAHMELİKOĞLU ONUR
Deniz KARABIÇAK
Pages
31–38
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Pre and post CBT scale scores were also statistically significant in terms of FIQ and TAS subgroups (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The current study aimed to evaluate the role of Cognitive Behavioral Therapy (CBT) on pain, anxiety, alexithymia, depression and functional status in female patients with Fibromyalgia syndrome (FMS).
📊
Key Findings & Data:Twenty female patients with FMS after the evaluation with socidemographic and clinic data form, who attended 12 CBT sessions (40 minutes) regularly, were included in the study.
💡
Conclusion & Impact:Pre and post CBT scale scores were also statistically significant in terms of FIQ and TAS subgroups (p
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The current study aimed to evaluate the role of Cognitive Behavioral Therapy (CBT) on pain, anxiety, alexithymia, depression and functional status in female patients with Fibromyalgia syndrome (FMS). Twenty female patients with FMS after the evaluation with socidemographic and clinic data form, who attended 12 CBT sessions (40 minutes) regularly, were included in the study. The Beck Depression Inventory (BDI) for depression severity, Toronto Alexithymia Scale (TAS) for alexithymia level, Beck Anxiety Inventory (BAI) for anxiety level, Visual Analogue Scale (VAS) for pain severity and the Fibromiyalgia Impact Questionnaire (FIQ) for functional status, tests were administered pre and post CBT. FMS patients with the mean age 48.7±10.2 years, had statistically significant difference between pre CBT and post CBT in terms of BDI (p=0.000), VAS (p=0.000), and BAI (p=0.001) scores. Pre and post CBT scale scores were also statistically significant in terms of FIQ and TAS subgroups (p

Özet

Bu çalışmada Bilişsel Davranışçı Terapi’nin (BDT) Fibromiyalji Sendromu (FMS) tanılı kadın hastalarda ağrı yoğunluğu, aleksitimi, depresyon, anksiyete ve fonksiyonel kapasitelerinin üzerine etkisinin araştırılması amaçlanmıştır. FMS tanısı almış, demografik ve klinik özelliklerine yönelik değerlendirme yapıldıktan sonra, en az haftada bir kere, 12 seans, 40 dakikalık yapılandırılmış BDT görüşmelerine düzenli bir şekilde gelen 20 kadın hasta çalışmaya dâhil edildi. BDT görüşmelerinin başında ve sonlandırma aşamasında bireylerin Görsel Ağrı Skalası (GAS), Beck Depresyon Ölçeği (BDÖ), Beck Anksiyete Ölçeği (BAÖ), Toronto Aleksitimi Ölçeği (TAÖ), Fibromiyalji Etki Anketi (FEA) ile değerlendirildi. FMS hastaların yaş ortalaması 48,7±10,2 idi. BDT öncesine göre sonrasında BDÖ (p=0,000), GAS (p=0,000), ve BAÖ (p=0,001) skorları istatistiksel olarak anlamlı ölçüde azalmıştı. FEA alt grupları ve TAÖ alt grupları açısından da anlamlı farklılık mevcut idi (p

🔖

Cite This Article

TEKSİN, G., ONUR, Ö. Ş., KARABIÇAK, D. (2022). Cognitive Behavioral Therapy for Female Patients with Fibromyalgia Syndrome: A Pilot Trial. Bilişsel Davranışçı Psikoterapi ve Araştırmalar Dergisi, Cilt: 11 - Sayı: 1, 31–38. https://ajindex.com/articles/649136

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Babaoğlu, G., İnan, L. E., & Özdel, K. (2017). Bilişsel Davranışçı Terapinin Kronik Ağrı Tedavisindeki Yeri. JCBPR, 6(3),133-140. https://doi.org/10.5455/JCBPR.263365
  2. Bagby, R. M., Parker, J. D. A., & Taylor, G. J. (1994). The 20- Item Toronto-Alexithymia-Scale-1. Item Selection and Cross- Validation of the Factor Structure. J Psychosom Res, 38, 23-32. https://doi.org/10.1016/0022-3999(94)90005-1
  3. Bagby, R. M., Taylor, G. J., & Parker, J. D. (1994). A. The 20-Item Toronto-Alexithymia-Scale-2. Convergent, Discriminant, and Concurrent Validity. J Psychosom Res, 38, 33-40. https://doi. org/10.1016/0022-3999(94)90006-X Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988). An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol, 56, 893-897. https://doi.org/10.1037/0022- 006X.56.6.893 Beck, A. T., Ward, C. H., Mendelson, M., Mock, J., & Erbaugh, J. (1961). An inventory for measuring depression. Arch Gen Psychiatry, 4, 561-571. https://doi:10.1001/archpsyc.1961.01710120031004
  4. Bernardy, K., Klose, P., Busch, A. J., Choy, E. H., & Hauser, W. (2013). Cognitive behavioural therapies for fibromyalgia. Cochrane Database Syst Rev, 9. https://doi.org/10.1002/14651858.CD009796.pub2
  5. Bernardy, K., Klose, P., Welsch, P., & Häuser, W. (2018). Efficacy, acceptability and safety of cognitive behavioural therapies in fibromyalgia syndrome –A systematic review and meta analysis of randomized controlled trials. Eur J Pain, 22(2), 242-260. https:// doi.org/10.1002/ejp.1121 Brosschot, J. F., & Aarsse, H.R. (2001). Restricted emotional processing and somatic attribution in fibromyalgia. Int J Psychiatry Med, 31, 127-146. https://doi.org/10.2190/K7AU-9UX9-W8BW-TETL
  6. Burckhardt, C. S., Clark, S. R., & Bennett, R. M. (1991). The fibromyalgia impact questionnaire: development and validation. J Rheumatol, 18, 728-733. https://pubmed.ncbi.nlm.nih. gov/1865419/ Di Tella, M., Enrici, I., Castelli, L., Colonna, F., Fusaro, E., Ghiggia, A.,., & Adenzato, M. (2018). Alexithymia, not fibromyalgia, predicts the attribution of pain to anger-related facial expressions. J Affect Disord, 227, 272-279. https://doi.org/10.1016/j.jad.2017.10.048
  7. Falcao, D. M., Sales, L., Leite, J. R., Feldman, D., Valim, V., & Natour, J. (2008). Cognitive-behavioral therapy for the treatment of fibromyalgia syndrome: A randomized controlled trial. J Musculoskelet Pain, 16, 133-140. https://doi. org/10.1080/10582450802161796 Galvez-Sánchez, C. M., Montoro, C. I., Duschek, S.,